Septra ds and Haemolysis - from FDA reports
Haemolysis is found among people who take Septra ds, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Flovent, and have Type 1 diabetes. This review analyzes which people have Haemolysis with Septra ds. It is created by eHealthMe based on reports of 1,546 people who have side effects when taking Septra ds from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 17, 2017
1,546 people reported to have side effects when taking Septra ds.
Among them, 6 people (0.39%) have Haemolysis
Number of reports submitted per year:
Time on Septra ds when people have Haemolysis *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Haemolysis when taking Septra ds *:
- female: 16.67 %
- male: 83.33 %
Age of people who have Haemolysis when taking Septra ds *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 16.67 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 83.33 %
Top conditions involved for these people *:
- Wound Infection (1 person, 16.67%)
- Type 1 Diabetes (1 person, 16.67%)
Top co-used drugs for these people *:
- Tylenol (5 people, 83.33%)
- Flovent (5 people, 83.33%)
- Ventolin (4 people, 66.67%)
- Dilaudid (4 people, 66.67%)
- Cefotaxime (4 people, 66.67%)
Top other side effects for these people *:
- Jaundice - Yellow Skin (4 people, 66.67%)
- Haemoglobin Decreased (3 people, 50.00%)
- Blood Bilirubin Increased (3 people, 50.00%)
- Low Density Lipoprotein Increased (2 people, 33.33%)
- Cold Agglutinins Positive (2 people, 33.33%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Haemolysis when taking Septra ds?
Septra ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. (latest outcomes from Septra ds 1,701 users)
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid) has been reported by people with paroxysmal nocturnal haemoglobinuria, preventive health care, high blood pressure, chronic lymphocytic leukaemia, idiopathic thrombocytopenic purpura (latest reports from 5,727 Haemolysis patients).